Medical Device Industry News

Medtronic unveils post-merger management structure

October 30, 2014 by Val Kennedy

Medtronic CEO Omar Ishrak unveils the plan for the medical device giant's management structure after it closes its mega-merger with Covidien early next year.

Medtronic unveils post-merger management structure

MassDevice.com +3 | The top 3 medtech stories for October 30, 2014

October 30, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Pelvic mesh lawsuits push Coloplast's annual profits down

October 30, 2014 by Brad Perriello

Coloplast posts its 1st profits decline in 7 years on mounting legal costs stemming from U.S. product liability lawsuits filed over its pelvic mesh products.

Pelvic mesh lawsuits push Coloplast's annual profits down

Smith & Nephew gains on Q3 results

October 30, 2014 by Brad Perriello

Shares of Smith & Nephew are up today on solid 3rd-quarter results, including 6% growth for its U.S. hip implant business.

Smith & Nephew gains on Q3 results

Medtronic issues update on debt financing before Covidien merger | Medtech Wall Street news for the week of October 27, 2014

October 30, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic updates on $43B Covidien deal financing; Boston Scientific, Bard CEOs cool on consolidation; Nevro sets range for IPO of up to $106m; Alere to sell Alere Health unit to Optum for $600m; Skyline Medical conducts 1-for-75 reverse stock split

Medtronic updates on $43B Covidien deal financing

October 24, 2014 by Brad Perriello

Abiomed jumps on FDA deal for Impella indication

October 30, 2014 by Brad Perriello

Abiomed says it's come to an agreement with the FDA on an indication for its flagship Impella 2.5 heart pump, and now expects to win pre-market approval early next year without a hearing before an FDA advisory panel.

Abiomed jumps on deal with FDA

Medtronic, Covidien merger expected to close in 2015

October 30, 2014 by Brad Perriello

Medtronic and Covidien say their pending, $43 billion merger is expected to close in early 2015.

Medtronic, Covidien merger expected to close in 2015
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp